ClinInnov: what changed
What changed
ClinInnov
NACE 72.101, Research and development on biotechnology
filed annual accounts (NBB)
Net result for the year
€124,241
2024 · €113,966+€10,274
Equity
€237,541
2024 · €114,133+€123,408
Cash
€308,244
2024 · €146,974+€161,269
Balance sheet total
€361,049
2024 · €212,072+€148,976
Largest movements
Assets
- Cash +€161,269
up €161,269 (+110%), from €146,974 to €308,244
mainly Net result for the year (+€124,241) and Tax, wage and social debts (+€37,762)
- Tangible fixed assets -€13,613
down €13,613 (-27.3%), from €49,897 to €36,284
Equity and liabilities
- Reserves +€123,408
up €123,408 (+109%), from €113,133 to €236,541
- Tax, wage and social debts +€37,762
up €37,762 (+94.4%), from €40,016 to €77,778
- Debts after one year -€16,103
down €16,103 (-42.6%), from €37,820 to €21,717
Income statement
- Gross operating margin +€11,745
up €11,745 (+7.1%), from €164,808 to €176,553
- Taxes +€3,299
up €3,299 (+10.0%), from €32,913 to €36,213
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€113,966
Gross operating margin
+€11,745
Depreciation
+€712
Other operating charges
+€226
Financial charges
+€891
Taxes
-€3,299
Result 2025
€124,241
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€178,121
Investment
-€440
Financing
-€16,411
Cash 2024
€146,974
From operations (derived)
+€178,121
Net result for the year
+€124,241
Depreciation
+€14,053
Receivables within one year
-€1,163
Smaller working-capital items
-€90
Tax, wage and social debts
+€37,762
Other debts
+€3,318
Investment (derived)
-€440
Investment in fixed assets (net)
-€440
Financing
-€16,411
Debts after one year
-€16,103
Current portion of long-term debt
+€525
Contributions, distributions and other
-€833
Cash 2025
€308,244
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €212,072 | €361,049 | +€148,976 | +70.2% |
| Fixed assets | 21/28 | €49,897 | €36,284 | -€13,613 | -27.3% |
| Tangible fixed assets | 22/27 | €49,897 | €36,284 | -€13,613 | -27.3% |
| Furniture and vehicles | 24 | €49,897 | €36,284 | -€13,613 | -27.3% |
| Current assets | 29/58 | €162,176 | €324,765 | +€162,589 | +100% |
| Amounts receivable within one year | 40/41 | €14,000 | €15,163 | +€1,163 | +8.3% |
| Trade receivables | 40 | €14,000 | €15,163 | +€1,163 | +8.3% |
| Cash at bank and in hand | 54/58 | €146,974 | €308,244 | +€161,269 | +110% |
| Deferred charges and accrued income | 490/1 | €1,202 | €1,358 | +€156 | +13.0% |
| Total equity and liabilities | 10/49 | €212,072 | €361,049 | +€148,976 | +70.2% |
| Equity | 10/15 | €114,133 | €237,541 | +€123,408 | +108% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €113,133 | €236,541 | +€123,408 | +109% |
| Distributable reserves | 133 | €113,133 | €236,541 | +€123,408 | +109% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €97,939 | €123,508 | +€25,569 | +26.1% |
| Amounts payable after more than one year | 17 | €37,820 | €21,717 | -€16,103 | -42.6% |
| Financial debts | 170/4 | €37,820 | €21,717 | -€16,103 | -42.6% |
| Amounts payable within one year | 42/48 | €60,119 | €101,791 | +€41,672 | +69.3% |
| Current portion of amounts payable after more than one year | 42 | €10,528 | €11,053 | +€525 | +5.0% |
| Trade debts | 44 | €178 | €243 | +€66 | +37.1% |
| Suppliers | 440/4 | €178 | €243 | +€66 | +37.1% |
| Taxes, remuneration and social security | 45 | €40,016 | €77,778 | +€37,762 | +94.4% |
| Taxes | 450/3 | €40,016 | €77,778 | +€37,762 | +94.4% |
| Other amounts payable | 47/48 | €9,397 | €12,716 | +€3,318 | +35.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,765 | €14,053 | -€712 | -4.8% |
| Other operating charges | 640/8 | €260 | €34 | -€226 | -86.8% |
| Gross operating margin | 9900 | €164,808 | €176,553 | +€11,745 | +7.1% |
| Operating profit (loss) | 9901 | €149,783 | €162,465 | +€12,683 | +8.5% |
| Financial charges | 65/66B | €2,903 | €2,012 | -€891 | -30.7% |
| Recurring financial charges | 65 | €2,903 | €2,012 | -€891 | -30.7% |
| Profit (loss) for the period before taxes | 9903 | €146,880 | €160,453 | +€13,574 | +9.2% |
| Income taxes | 67/77 | €32,913 | €36,213 | +€3,299 | +10.0% |
| Profit (loss) for the period | 9904 | €113,966 | €124,241 | +€10,274 | +9.0% |
| Profit (loss) for the period to be appropriated | 9905 | €113,966 | €124,241 | +€10,274 | +9.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.